Financhill
Back

Veracyte Stock Predictions

Veracyte Stock Forecast

  • Over the next 52 weeks, Veracyte has on average historically risen by 23.5% based on the past 11 years of stock performance.
  • Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
  • Is Veracyte Stock Undervalued?
    The current Veracyte [VCYT] share price is $26.82. The Score for VCYT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • VCYT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Veracyte Stock Go Up Next Year?

  • Over the next 52 weeks, Veracyte has on average historically risen by 23.5% based on the past 11 years of stock performance.

Veracyte Stock Rating

Buy
58
Veracyte (VCYT) is a Buy

Is Veracyte overpriced?

  • Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

Veracyte Stock Price History

Is VCYT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VCYT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
veracyte.com

52-Week Data

52-Week High:
47.32
52-Week Low:
19.73

Prediction Charts

Market Cap:
2.1B
Price in USD:
26.82
Volume:
687.4K
Beta:
1.51

Technical Analysis

SMA50:
29.23
SMA100:
32.78
SMA200:
34.93
52-Wk Change:
25.27%

Stock Predictions

  • Is Veracyte stock public?
    Yes, Veracyte is a publicly traded company.
  • What is the Veracyte stock quote today?
    The Veracyte stock price is 26.82 USD today.
  • How to buy Veracyte stock online?
    You can buy Veracyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-30 26.73 26.61 27.54 26.32
Jun-2 26.57 26.74 27.13 26.05
Jun-3 26.76 26.50 27.02 26.24
Jun-4 26.66 27.29 27.43 26.66
Jun-5 27.51 26.98 27.58 26.73
Jun-6 27.61 27.46 28.07 27.10
Jun-9 27.94 27.85 28.27 27.18
Jun-10 28.11 27.88 28.41 27.50
Jun-11 27.95 27.93 28.43 27.52
Jun-12 27.65 26.69 27.86 26.52
Jun-13 26.39 26.44 27.01 26.20
Jun-16 26.46 26.64 26.92 25.85
Jun-17 26.42 26.76 26.84 25.91
Jun-18 26.69 26.82 27.11 25.99

Veracyte Earnings

Veracyte Earnings Report: Per Share Veracyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Veracyte Forecast Revenue Growth

Veracyte Stock Analysis: Historical quarterly revenues per share for Veracyte and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.03 per share, an increase this year of $0.29 per share, and an increase next year of $0.04 per share.

* Veracyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.